Ocugen (OCGN) Shares Outstanding (Diluted Average) (2019 - 2026)

Ocugen (OCGN) reported Shares Outstanding (Diluted Average) of $327.5 million for Q1 2026, up 12.17% on a YoY basis from $292.0 million in Q1 2025, and up 12.17% quarter-over-quarter from $292.0 million in Q1 2025.

Ocugen (OCGN) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends

Ocugen has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $327.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 12.17% year-over-year to $327.5 million; the trailing twelve-month figure through Mar 2026 stood at $327.5 million (up 12.17% YoY), and the FY2024 full-year result was $54745.0, down 99.98% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $327.5 million, up from $292.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $327.5 million in Q1 2026, with the low at $54745.0 in Q4 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $227.9 million across 5 years, with a median of $232.0 million in 2023.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) rose 20.56% — and 2024, when it sank 99.98%.
  • Ocugen's Shares Outstanding (Diluted Average) stood at $214.6 million in 2022, then climbed by 13.85% to $244.3 million in 2023, then slumped by 99.98% to $54745.0 in 2024, then soared by 533275.76% to $292.0 million in 2025, then grew by 12.17% to $327.5 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $327.5 million (Q1 2026), $292.0 million (Q1 2025), and $54745.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Ocugen 411.07 Mn 411.07 Mn - 327.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 327.54 Mn
Mar 31, 2025 292.00 Mn
Dec 31, 2024 54,745.00
Sep 30, 2024 278.17 Mn
Jun 30, 2024 257.35 Mn
Dec 31, 2023 244.33 Mn
Sep 30, 2023 256.49 Mn
Jun 30, 2023 231.95 Mn
Mar 31, 2023 225.52 Mn
Dec 31, 2022 214.60 Mn
Sep 30, 2022 212.76 Mn
Jun 30, 2022 215.86 Mn
Mar 31, 2022 205.69 Mn
Dec 31, 2021 195.01 Mn
Sep 30, 2021 198.79 Mn
Jun 30, 2021 195.57 Mn
Mar 31, 2021 186.30 Mn
Dec 31, 2020 112.24 Mn
Sep 30, 2020 92.76 Mn
Jun 30, 2020 83.54 Mn